During the past decade, SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 12 clinical trials were completed, i.e. on average, 109.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Biocad" with 3 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored, "R-Pharm International, LLC" with 2 trials sponsored and "Sunovion" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Mene Research" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary" are "Breast Cancer" (4 trials), "Cervical Cancer" (2 trials), "Rheumatoid Arthritis" (2 trials), "Schizophrenia" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary" in a lesser frequency.

Most popular intervention types in "SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary" are "Drug" (19 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Paclitaxel" (6 trials), "Docetaxel" (4 trials), "5-Fluorouracil" (3 trials) and "BCD-100" (3 trials). Other intervention names were less common.

The vast majority of trials in "SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary" are 15 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary has several departments that took part in Clinical trials: "Regional Children's Clinical Hospital" - 2 trials